Search research articles
Contact Us
Filters
Showing results (491-500 of 594) with videos related to
Page
of 60
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 21, 2020
Evolution of Genomic and T-cell Repertoire Heterogeneity of Malignant Pleural Mesothelioma Under Dasatinib Treatment
Runzhe Chen, Won-Chul Lee, Junya Fujimoto, et al.
Cancers
|
July 27, 2022
Limited Benefit from the Addition of Immunotherapy to Chemotherapy in TKI-Refractory EGFR-Mutant Lung Adenocarcinoma
Lingzhi Hong, Whitney E Lewis, Monique Nilsson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 21, 2023
ATM Mutations Associate with Distinct Co-Mutational Patterns and Therapeutic Vulnerabilities in NSCLC
Natalie I Vokes, Ana Galan Cobo, Margarita Fernandez-Chas, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 2, 2026
Brief Report: SARS-CoV-2 mRNA Vaccination Improved Survival in NSCLC Treated with Radiotherapy
Xinyan Xu, Maliazurina B Saad, Adam Grippin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2020
Impact of Neoadjuvant Durvalumab with or without Tremelimumab on CD8<sup>+</sup> Tumor Lymphocyte Density, Safety, and Efficacy in Patients with Oropharynx Cancer: CIAO Trial Results
Renata Ferrarotto, Diana Bell, Maria L Rubin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2021
Multiplex Tissue Imaging Harmonization: A Multicenter Experience from CIMAC-CIDC Immuno-Oncology Biomarkers Network
Guray Akturk, Edwin R Parra, Evisa Gjini, et al.
Nature Medicine
|
April 24, 2019
Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial
Jordi Rodon, Jean-Charles Soria, Raanan Berger, et al.
Cancers
|
May 14, 2025
Lung Cancer Risk Prediction in Patients with Persistent Pulmonary Nodules Using the Brock Model and Sybil Model
Hui Li, Morteza Salehjahromi, Myrna C B Godoy, et al.
Cancer
|
July 19, 2002
The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: potential for decreased toxicity and combination with biological therapy
Roy S Herbst, Fadlo R Khuri, Charles Lu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 20, 2012
Redesigning radiotherapy quality assurance: opportunities to develop an efficient, evidence-based system to support clinical trials--report of the National Cancer Institute Work Group on Radiotherapy Quality Assurance
Justin E Bekelman, James A Deye, Bhadrasain Vikram, et al.
Page
of 60
Search research articles
Search
Showing results (491-500 of 594) with videos related to
Sort By:
Page
of 60
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 21, 2020
Evolution of Genomic and T-cell Repertoire Heterogeneity of Malignant Pleural Mesothelioma Under Dasatinib Treatment
Runzhe Chen, Won-Chul Lee, Junya Fujimoto, et al.
Cancers
|
July 27, 2022
Limited Benefit from the Addition of Immunotherapy to Chemotherapy in TKI-Refractory EGFR-Mutant Lung Adenocarcinoma
Lingzhi Hong, Whitney E Lewis, Monique Nilsson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 21, 2023
ATM Mutations Associate with Distinct Co-Mutational Patterns and Therapeutic Vulnerabilities in NSCLC
Natalie I Vokes, Ana Galan Cobo, Margarita Fernandez-Chas, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 2, 2026
Brief Report: SARS-CoV-2 mRNA Vaccination Improved Survival in NSCLC Treated with Radiotherapy
Xinyan Xu, Maliazurina B Saad, Adam Grippin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2020
Impact of Neoadjuvant Durvalumab with or without Tremelimumab on CD8<sup>+</sup> Tumor Lymphocyte Density, Safety, and Efficacy in Patients with Oropharynx Cancer: CIAO Trial Results
Renata Ferrarotto, Diana Bell, Maria L Rubin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2021
Multiplex Tissue Imaging Harmonization: A Multicenter Experience from CIMAC-CIDC Immuno-Oncology Biomarkers Network
Guray Akturk, Edwin R Parra, Evisa Gjini, et al.
Nature Medicine
|
April 24, 2019
Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial
Jordi Rodon, Jean-Charles Soria, Raanan Berger, et al.
Cancers
|
May 14, 2025
Lung Cancer Risk Prediction in Patients with Persistent Pulmonary Nodules Using the Brock Model and Sybil Model
Hui Li, Morteza Salehjahromi, Myrna C B Godoy, et al.
Cancer
|
July 19, 2002
The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: potential for decreased toxicity and combination with biological therapy
Roy S Herbst, Fadlo R Khuri, Charles Lu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 20, 2012
Redesigning radiotherapy quality assurance: opportunities to develop an efficient, evidence-based system to support clinical trials--report of the National Cancer Institute Work Group on Radiotherapy Quality Assurance
Justin E Bekelman, James A Deye, Bhadrasain Vikram, et al.
Page
of 60